Diagnostic Feasibility of 100 Hz Tetanic Stimulation

March 26, 2025 updated by: Pongrácz Adrienn, University of Debrecen

Diagnostic Feasibility of 100 Hz Tetanic Stimulation in the Perioperative Setting in Patients with Normal and Abnormal ENG: a Pilot Study

The goal of this observational study is to investigate the applicability of 100 Hz tetanic stimulation with an electromyography device in the exclusion of postoperative residual neuromuscular block. The aim is to determine whether fatigue develops with 100 Hz tetanic stimulation in anaesthetized, non-relaxed patients with normal or abnormal baseline electroneurographic (ENG) findings.

Study Overview

Status

Recruiting

Conditions

Detailed Description

The aim of the present study is to investigate the applicability of 100 Hz tetanic stimulation with an electromyography (EMG) device. The aim is to determine whether fatigue develops with 100 Hz tetanic stimulation in anaesthetized, non-relaxed patients with normal or abnormal baseline electroneurographic (ENG) findings. Electric responses of the musculus digiti minimi elicited by supramaximal stimulation of the ulnar nerve at the carpal tunnel are monitored. Alpine Biomed ENG-EMG device with Keypoint software version 5.11 is used for the examinations. The exposed arm is fixed on the armboard, the skin is degreased and then the electrodes for monitoring are mounted lege artis. After the anesthesia has been induced, ENG of the ulnar nerve is examined. Based on the results of the ENG test, patients are divided into separate groups (normal or abnormal ENG). During the ENG test, the supramaximal current is determined. Afterwards, repetitive tetanic stimulation of the defined frequency (60 and 100 Hz) and duration (5 sec) is applied to the two test groups at the current according to the test plan.

The clinical utilities of the study results are:

  • Determination of the "safety margin" of neuromuscular junction, which is not provided by routine monitoring.
  • To investigate how comorbid status (especially chronic conditions affecting peripheral nerves such as polyneuropathy) influences the feasibility of tetanic stimulation in the diagnostics of residual neuromuscular block and safety margin.

Study Type

Observational

Enrollment (Estimated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Debrecen, Hungary, 4032
        • Recruiting
        • University of Debrecen Medical Center, Department of Anesthesiology and Intensive Care
    • Hajdú-Bihar
      • Debrecen, Hajdú-Bihar, Hungary, 4032
        • Not yet recruiting
        • Department of Anesthesiology and Intensive Care, University of Debrecen
        • Contact:
        • Contact:
        • Contact:
          • Mariann Fedor, MD
        • Contact:
          • Adrienn Pongrácz, MD PhD
        • Contact:
          • Réka Nemes, MD PhD
        • Contact:
          • László Asztalos, MD PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Surgical patients

Description

Inclusion Criteria:

  • ASA 1-3;
  • BMI 18.5-25 (normal body weight);
  • patient is in supine position with one arm accessible.

Exclusion Criteria:

  • diseases with impaired neuromuscular function (myopathies, severe liver and kidney failure);
  • drugs affecting neuromuscular function (magnesium, aminoglycosides);
  • pregnancy (pregnancy tests are carried out in women of childbearing age to rule out pregnancy);
  • breast-feeding;
  • acute surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Normal ENG
Patients who have normal results at baseline electroneurogrphy examination
Abnormal ENG
Patients who have abnormal results at baseline electroneurogrphy examination due to polyneuropathy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
100 Hz tetanic fade response of abductor digiti minimi muscle to ulnar nerve stimulation in patients with normal and abnormal ENG
Time Frame: From enrollment until end of anesthesia asessed up to 1 hour. No further ENG measurements are performed in the postoperative period.
Electroneurography response of the abductor digiti minimi muscle to 100 Hz tetanic stimulation (tetanic fade) is examined to find out if there is difference in patients with or without polyneuropathy. Tetanic fade is the decrease of the twitch heights of the compound muscle action potential due to depletion of cetylcholin stores in the nerve terminal during tetanic stimulation.
From enrollment until end of anesthesia asessed up to 1 hour. No further ENG measurements are performed in the postoperative period.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diagnostic feasibility of electromyography in the examination of safety margin
Time Frame: From enrollment until end of anesthesia assessed up to 1 hour. No further ENG measurements are performed in the postoperative period.
To see whether tetanic stimulation with electromyography can be used as a routine tool to examine the safety margin and residual neuromuscular block. It is expected that there will be no fade in muscle response to 60 Hz tetanic stimulation in either groups. It is suspected that there will be no tetanic fade response to 100 Hz tetanic stimulation in patinets with normal ENG, however patinets with abnormal baseline ENG will produce tetanic fade. The incidence and extent of tetanic fade response will be examined.
From enrollment until end of anesthesia assessed up to 1 hour. No further ENG measurements are performed in the postoperative period.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
60 Hz tetanic fade response of abductor digiti minimi muscle to ulnar nerve stimulation in patients with normal and abnormal ENG
Time Frame: From enrollment until end of anesthesia assessed up to 1 hour. No further ENG measurements are performed in the postoperative period.
Electroneurography response of the abductor digiti minimi muscle to 60 Hz tetanic stimulation (tetanic fade) is examined to find out if there is difference in patients with or without polyneuropathy. Tetanic fade is the decrease of the twitch heights of the compound muscle action potential due to depletion of cetylcholin stores in the nerve terminal during tetanic stimulation.
From enrollment until end of anesthesia assessed up to 1 hour. No further ENG measurements are performed in the postoperative period.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Béla Fülesdi, MD PhD DSci, University of Debrecen

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 6, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

December 5, 2024

First Submitted That Met QC Criteria

December 23, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 27, 2025

Last Update Submitted That Met QC Criteria

March 26, 2025

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Polyneuropathies

Subscribe